Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
06/2004
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1423187A1 Solid-liquid reaction
06/02/2004EP1423136A1 Polypeptide conjugates with extended circulating half-lives
06/02/2004EP1423107A2 Fatty alcohol drug conjugates
06/02/2004EP1242433B1 Use of a supplemental promoter in conjunction with a carbon-supported, noble-metal-containing catalyst in liquid phase oxidation reactions
06/02/2004EP1230249B1 Transition metal complexes with bidentate ligand having an imidazole ring
06/02/2004EP1008599B1 Copper phosphoric ester compounds and process for producing the same, near infrared absorber, and near infrared absorbent acrylic resin composition
06/02/2004CN1501940A Composition and method for inhibiting platelet aggregation
06/02/2004CN1501903A Stable solution of reduced coenzyme q
06/02/2004CN1500813A Polymerization with living characteristics
06/02/2004CN1500792A Normal temperature four in one cleaning agent using in industry
06/02/2004CN1500791A Purifying method for high purity phosphatidylcholine phospholipid
06/02/2004CN1152073C Isocyanate compositions, coatings producing method using the same and coatings obtained
06/02/2004CN1152035C Furylphosphines and organometallic complexes containing the same
06/02/2004CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
06/01/2004US6743947 Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors
06/01/2004US6743937 Water solubility; angiogenesis inhibitor, anticancer agents
06/01/2004US6743921 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
06/01/2004US6743878 Polymeric surface coatings
06/01/2004US6743827 Method for preparing colloidal solution of bismuth sodium tartrate
06/01/2004US6743786 Vanadium compounds for treating cancer
06/01/2004US6743784 Triarylethanes for treating symptoms, diseases and conditions in extra-reproductive tract tissues, such as osteopenia, that are responsive to treatment with estrogen
06/01/2004CA2095813C Medicated syringe preparation
05/2004
05/27/2004WO2004043973A1 Novel intermediate for carbapenem compound for oral administration and process for producing the same
05/27/2004WO2004043972A1 A new crystal form of adefovir dipivoxil and its composition
05/27/2004WO2004043971A1 Phosphinic acid analogs of glutamate
05/27/2004WO2004043970A1 Novel lipophilic compounds and uses thereof
05/27/2004WO2004043933A1 Ophthalmic compositions for treating ocular hypertension
05/27/2004WO2004043932A1 Ophthalmic compositions for treating ocular hypertension
05/27/2004WO2004043359A2 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
05/27/2004WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/27/2004WO2002099141A9 Fluorescent quenching detection reagents and methods
05/27/2004US20040102649 Water soluble chiral diphoshpines
05/27/2004US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections
05/27/2004US20040102516 Crop protection agents
05/27/2004US20040102386 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto
05/27/2004US20040102323 Solid herbicidal formulation of N-(phosphono-methyl)glycine and process for its preparation
05/27/2004US20040101897 Production method for purine nucleotide derivative disodium crystals and alcohol removing method
05/27/2004US20040101892 Nucleic acid labeling compounds
05/27/2004US20040101858 Modulation of hypoxia-inducible factor 1 alpha expression
05/27/2004US20040098847 Funerary container made of paper material, and assembly device employed therein
05/27/2004DE10252451A1 Flotation agent for sulfide ore, e.g. non-ferrous copper, nickel, zinc, lead or molybdenum sulfide ore, contains diorganyl alkylamidothiophosphate, preferably prepared by oxidizing dithiophosphate in acid solution, then reacting with amine
05/27/2004CA2505414A1 Lipophilic phosphoramide compounds and uses thereof
05/26/2004EP1422232A1 Method of obtaining cis-1-propenylphosphonate of diterbutyl
05/26/2004EP1422216A1 Fluorine compound and fluorinating agent comprising the compound
05/26/2004EP1421941A1 Phospholipid derivatives having a polyhydroxylated aliphatic carbocycle
05/26/2004EP1421927A1 Dental self-etching primer
05/26/2004EP1421139A2 Higher alkylated triaryl phosphate ester flame retardants
05/26/2004EP1421092A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same
05/26/2004EP1421056A1 (alpha)-haloenamine reagents
05/26/2004EP1421050A1 Process to bromomethylate aromatic compounds
05/26/2004EP1420825A2 Immunomodulatory compounds and methods of use thereof
05/26/2004EP1161226B1 Phosphocholine linked prodrug derivatives
05/26/2004EP1114023B1 Process for preparing carboxylic acids
05/26/2004EP1104766B1 Cross-linked phenoxyphosphazene compound, process for producing the same, flame retardant, flame-retardant resin composition, and molded flame-retardant resin
05/26/2004EP1084134A4 Activators for oligonucleotide synthesis
05/26/2004CN1498890A Crystalline form of Adefovir ester and preparation method
05/26/2004CN1151162C Substitued phenoxy acetoxyl alkyl hypohyosphorous ester with herbicide activity and preparation
05/26/2004CN1151161C Medicine nitrate salts
05/26/2004CN1151160C Process for extracting phosphatidecoline from powdered soybean phosphatide
05/25/2004US6740732 Phosphorus element-containing crosslinking agents and flame retardant phosphorus element-containing epoxy resin compositions prepared therewith
05/25/2004US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
05/25/2004CA2100552C Preparation of 2-(pyridyl)ethyl substituted phosphorous compounds
05/25/2004CA2048172C Substituted sulfonamids, preparation processes and drugs containing same
05/21/2004WO2004042784A2 Stabilized semiconductor nanocrystals
05/21/2004WO2004041837A1 Novel cytarabine monophosphate prodrugs
05/21/2004WO2004041834A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
05/21/2004WO2004041805A1 NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&
05/21/2004WO2004041311A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
05/21/2004WO2004041167A2 Antiprotozoal ring-substituted phospholipids
05/21/2004WO2004020446A3 N-(2, 2, 2-trichloro-1-dialkylphosphonatoethyl) (meth)acrylamide, production thereof, use thereof as a comonomer for the production of methacryl foams, and self-extinguishing methacryl foams produced therewith
05/21/2004WO2003086605A3 Functionalized ionic liquids, and methods of use thereof
05/21/2004CA2503058A1 Antiprotozoal ring-substituted phospholipids
05/20/2004US20040097745 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
05/20/2004US20040097722 Preparation of phosphorothioate oligomers
05/20/2004US20040097670 Transition metal catalysts containing bidentate ligands and method of using and preparing same
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097575 For therapy of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient; to provide neuroprotective effect to the eye of mammals
05/20/2004US20040097554 For therapy and prophylaxis of autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral inflammation, transplantation tissue rejection, atherosclerosis, restenosis
05/20/2004US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders
05/20/2004US20040097471 For therapy and prophylaxis of influenza infection
05/20/2004US20040096393 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain)
05/20/2004US20040094741 Ionic liquids, electrolyte salts for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery
05/19/2004EP1419815A1 Phosphine compounds, transition metal complexes with the compounds contained as ligands therein, and asymmetric synthesis catalysts containing the complexes
05/19/2004EP1419194A1 Phosphorus compounds as stabilizers
05/19/2004EP1419165A1 Isoxazoline derivatives as p, n ligands
05/19/2004EP1419129A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
05/19/2004EP1242358B1 Catalyst composition and method for producing diaryl carbonates, using bisphosphines
05/19/2004EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts
05/19/2004EP0970078B1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/19/2004CN1497043A 润滑油组合物 The lubricating oil composition
05/19/2004CN1496991A Chirality monophosphorous compound and its transition metal compound
05/19/2004CN1150200C Process for preparing methylene bisphosphonic and salts
05/18/2004US6737553 Method for producing surfactant alcohols and surfactant alcohol ethers, the resulting products and their use
05/18/2004US6737549 Photoinitiators for acrylate coatings
05/18/2004US6737536 Inositolphospholipids and analogues
05/18/2004US6737526 Method for preparing melamine salt of bis-(pentaerythritol phosphate) phosphoric acid
05/18/2004US6737416 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B
05/18/2004US6737239 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents